Target intelligence / Profile preview

MicroRNA 4639 (miR-4639)

Target
miR-4639
Molecular classification
Other (Non-coding RNA, specifically microRNA)
01

Overview

MicroRNA 4639 (miR-4639, hsa-miR-4639, hsa-miR-4639-5p) is a small, non-coding RNA molecule that regulates gene expression post-transcriptionally, primarily by binding to complementary sequences in the 3′ untranslated region (UTR) of target messenger RNAs (mRNAs), leading to their degradation or translational repression. It has been shown to directly target the DJ-1 (PARK7) gene, a crucial antioxidant and neuroprotective protein. In Parkinson’s disease, elevated levels of miR-4639-5p in plasma are associated with reduced DJ-1 protein expression, contributing to increased neuronal oxidative stress and cell death. This has led to proposals for miR-4639-5p as a sensitive, non-invasive molecular biomarker for early Parkinson’s disease diagnosis and as a potential therapeutic target, although clinical translation requires further validation and safety testing.

Other names
hsa-miR-4639hsa-miR-4639-5pMIR4639
02

Mechanism of action

Inhibition or modulation of the microRNA itself to restore DJ-1 (PARK7) expression and potentially reduce oxidative stress and neuronal death

03

Biological functions

Gene silencing at the post-transcriptional level (mRNA degradation or translational repression)Regulation of oxidative stress responseModulator of DJ-1 (PARK7) gene expression
04

Disease associations

Neurodegenerative disease (notably Parkinson’s disease)Potential involvement in neuronal cell death
05

Safety considerations

The use of miRNA inhibitors could have off-target effects and may impact gene networks beyond DJ-1, requiring careful assessment in preclinical/clinical studiesDysregulation might affect non-target tissues given the broad regulatory roles of miRNAs
06

Interacting drugs

None reported as directly interacting; miR-4639 is a non-coding regulatory RNA, and current research is exploring antagonists (such as antisense oligonucleotides)
07

Biomarkers

Plasma hsa-miR-4639-5p is a potential early diagnostic biomarker for Parkinson’s disease, able to distinguish early-stage patients from healthy controlsReflects underlying neuropathology; especially CNS-derived exosomes contain this miRNA, correlating with central disease processes

Beyond the preview

Go deeper on MicroRNA 4639 (miR-4639).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4639 (miR-4639).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call